The ASPIRATOR publishes a broad range of papers covering topics in mosquito-borne diseases.Manuscripts and correspondence should be submitted through this site. To facilitate rapid publication and to minimize administrative costs, ASPIRATOR prefers online submission. Files can be submitted as a batch, or one by one. The submission process can be interrupted at any time; when users return to the site, they can carry on where they left off.
ASPIRATOR is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors.
Cover Letter and Signatures. All manuscripts should be accompanied by a cover letter.
The cover letter should address the following questions:
- Why is this manuscript suitable for publication in ASPIRATOR?
- Why will your study inspire researchers or readers, and how will it improve public health or drive the understanding of disease forward?
Structure of cover letter:
The title of the paper
A brief description of the significance of the paper to the readers of the ASPIRATOR
A statement confirming that the material is original, has not already been published, and has not and will not be submitted for publication elsewhere as long as it is under consideration by the ASPIRATOR. Download Ethical Statement.
Written disclosure of any relationships or support which might be perceived as constituting a conflict of interest. Download Potential Conflict of Interest form
Names and signatures of all contributing authors accompanied by a statement indicating that they have participated in the study and concur with the submission and subsequent revisions of the manuscript. Electronic signatures and multiple copies of the letter to facilitate gathering of signatures are acceptable, but it is preferable to submit signatures in one batch
The corresponding author must sign and return the License Agreement form upon submission. Download License Agreement Form.
Authorship. There is no limit to the number of authors that may be listed, but only those individuals who contributed substantially to the manuscript should be authors.
Changes to authorship. Author are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangements of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
File Formats. The following word processor file formats are acceptable for the main manuscript document:
- Microsoft word (DOC, DOCX)
- Rich text format (RTF)
- Portable document format (PDF)
You can download a template (Mac and Windows compatible; Microsoft Word 2010) for your article. If your article file is more than word 2010 please click the checklist in the section of "maintain compability with versions of word"
Article types. ASPIRATOR considers the following types of articles:
- Case Reports
- Methodology articles
- Systematic Reviews
- Short Communication
Currently, ASPIRATOR can accept manuscripts written both in Bahasa Indonesia and English. Spelling should be US English or British English, but not a mixture (if using English).
There is no explicit limit on the length of articles submitted, but authors are encouraged to be concise.
ASPIRATOR will not edit submitted manuscripts for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In-house copyediting will be minimal. Non-native speakers of English may choose to make use of a copyediting service.
Authors must check the EQUATOR Network site for any reporting guidelines that apply to the particular study design and ensure they include any required supporting information recommended by the relevant guidelines.
Reports of systematic reviews must adhere to the PRISMA Statement or alternative guidelines appropriate to the study design, and include the completed checklist and flow diagram to accompany the main text. Authors must complete the appropriate reporting checklist not only with page references, but also with sufficient text excerpted from the manuscript to explain how they accomplished all applicable items. ASPIRATOR does not publish narrative reviews.
For observational studies, including case control, cohort, and cross-sectional studies, authors must adhere to the STROBE Statement or alternative guidelines appropriate to the study design (see the EQUATOR web site) and include a completed checklist as supporting information. Authors must complete the appropriate reporting checklist not only with page references, but also with sufficient text excerpted from the manuscript to explain how they addressed all applicable items.
For observational studies, authors are required to clearly specify (a) What specific hypotheses the researchers intended to test, and the analytical methods by which they planned to test them; (b) What analyses they actually performed; and (c) When reported analyses differ from those that were planned, authors must provide transparent explanations for differences that affect the reliability of the study's results.
Main Manuscript Sections.
Title Page. The title page should:
- provide the title of the article
- list the full names, institutional addresses and email addresses for all authors
- indicate the corresponding author
Abstract. The Abstract of the manuscript should not exceed 250 words and must be structured into separate sections: Introduction, the context and purpose of the study; Methods, how the study was performed and statistical tests used; Results, the main findings; Conclusions, brief summary and potential implications. Please minimize the use of abbreviations and do not cite references in the abstract. Trial registration, if your research reports the results of a controlled health care intervention, please list your trial registry, along with the unique identifying number (e.g. Trial registration: Current Controlled Trials ISRCTN73824458). Please note that there should be no space between the letters and numbers of your trial registration number. We recommend manuscripts that report randomized controlled trials follow the CONSORT extensions.
Keywords. Three to five keywords representing the main content of the article.
Introduction. The Background section should be written in a way that is accessible to researchers without specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a brief statement of what is being reported in the article.
Methods. The methods section should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculation if appropriate. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Methods section.
For studies involving human participants a statement detailing ethical approval and consent should be included in the methods section. For further details of the journal's editorial policies and ethical guidelines see About.
Results. Results of statistical analysis should include, where appropriate, relative and absolute risks or risk reductions, and confidence intervals.
Discussion. This should state clearly the findings, limitations of the research and give a clear explanation of study, relevance, and deep. The findings and their implications should be discussed in the broadest context possible. Future research directions may also be highlighted.
Conclusions. This should state clearly the main conclusions of the research and give a clear explanation of their importance and relevance. Summary illustrations may be included.
Competing interest. A competing interest exists when your interpretation of data or presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors must disclose any financial competing interests; they should also reveal any non-financial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.
Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests. Use ICMJE Uniform Form for Potential Conflicts of Interest.
Author's contribution. In order to give appropriate credit to each author of a paper, the individual contributions of authors to the manuscript should be specified in this section.
Acknowledgment. Please acknowledge anyone who contributed towards the article by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include the source(s) of funding for each author, and for the manuscript preparation. Authors must describe the role of the funding body, if any, in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. Please also acknowledge anyone who contributed materials essential for the study. If a language editor has made significant revision of the manuscript, we recommend that you acknowledge the editor by name, where possible. The role of a scientific (medical) writer must be included in the acknowledgements section, including their source(s) of funding.
Reference. ASPIRATOR suggest you to use reference managers (EndNote, Zotero, or Mendeley). References must use standard ASPIRATOR formatting; please refer to prior issues of the Journal and the information below to assure correct formatting. We provide Aspirator journal style in mendeley, feel free to use it. References should be cited by consecutive numbers in the text. The numbers should appear in superscripts that appear after closing punctuation. References should be from peer-reviewed publications. Unpublished sources, including abstracts, conference proceedings, dissertations, and manuscripts not yet accepted for publication, should be cited in parentheses in the text as unpublished data or a personal communication (e.g. Kazura, J., personal communication). For details you can see Reference Writing Guidelines
To follow the writing style of the bibliography specified in the journal aspirator, then you can use the following link to help you in using mendeley reference manager.
Please copy the above link into the mendeley that you used. For more details, you can follow the steps in the mendeley update tutorial in next document mendeley tutorial
Article within a journal
Smith JJ. The world of science. Am J Sci. 1999;36:234-5.
Article by DOI (with page numbers)
O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging. 2004;31:555-63. doi:10.1007/s00259-003-1399-3
Article within a journal supplement
Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan. Blood 1979;59 Suppl 1:26-32.
Book chapter, or an article within a book
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p. 251-306.
Complete book, authored
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.